Literature DB >> 19630107

Bone mineral density and disorders of mineral metabolism in chronic liver disease.

Joe George1, Hosahithlu K Ganesh, Shrikrishna Acharya, Tushar R Bandgar, Vyankatesh Shivane, Anjana Karvat, Shobna J Bhatia, Samir Shah, Padmavathy S Menon, Nalini Shah.   

Abstract

AIM: To estimate the prevalence and identify the risk factors for metabolic bone disease in patients with cirrhosis.
METHODS: The study was performed on 72 Indian patients with cirrhosis (63 male, nine female; aged < 50 years). Etiology of cirrhosis was alcoholism (n = 37), hepatitis B (n = 25) and hepatitis C (n = 10). Twenty-three patients belonged to Child class A, while 39 were in class B and 10 in class C. Secondary causes for metabolic bone disease and osteoporosis were ruled out. Sunlight exposure, physical activity and dietary constituents were calculated. Complete metabolic profiles were derived, and bone mineral density (BMD) was measured using dual energy X ray absorptiometry. Low BMD was defined as a Z score below -2.
RESULTS: Low BMD was found in 68% of patients. Lumbar spine was the most frequently and severely affected site. Risk factors for low BMD included low physical activity, decreased sunlight exposure, and low lean body mass. Calcium intake was adequate, with unfavorable calcium: protein ratio and calcium: phosphorus ratio. Vitamin D deficiency was highly prevalent (92%). There was a high incidence of hypogonadism (41%). Serum estradiol level was elevated significantly in patients with normal BMD. Insulin-like growth factor (IGF) 1 and IGF binding protein 3 levels were below the age-related normal range in both groups. IGF-1 was significantly lower in patients with low BMD. Serum osteocalcin level was low (68%) and urinary deoxypyridinoline to creatinine ratio was high (79%), which demonstrated low bone formation with high resorption.
CONCLUSION: Patients with cirrhosis have low BMD. Contributory factors are reduced physical activity, low lean body mass, vitamin D deficiency and hypogonadism and low IGF-1 level.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19630107      PMCID: PMC2715978          DOI: 10.3748/wjg.15.3516

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  22 in total

1.  Effects of above average summer sun exposure on serum 25-hydroxyvitamin D and calcium absorption.

Authors:  M Janet Barger-Lux; Robert P Heaney
Journal:  J Clin Endocrinol Metab       Date:  2002-11       Impact factor: 5.958

Review 2.  Osteoporosis in liver diseases and after liver transplantation.

Authors:  J Eileen Hay
Journal:  J Hepatol       Date:  2003-06       Impact factor: 25.083

3.  A study of metabolic bone disorder in cirrhosis liver.

Authors:  S Sachdev; R C Bhasin; C K Kumari; M Reys
Journal:  J Assoc Physicians India       Date:  1976-01

Review 4.  AGA technical review on osteoporosis in hepatic disorders.

Authors:  William D Leslie; Charles N Bernstein; Meryl S Leboff
Journal:  Gastroenterology       Date:  2003-09       Impact factor: 22.682

Review 5.  Evaluation and management of osteoporosis in liver disease.

Authors:  J Eileen Hay; Maureen M J Guichelaar
Journal:  Clin Liver Dis       Date:  2005-11       Impact factor: 6.126

6.  Osteoporosis and skeletal fractures in chronic liver disease.

Authors:  T Diamond; D Stiel; M Lunzer; M Wilkinson; J Roche; S Posen
Journal:  Gut       Date:  1990-01       Impact factor: 23.059

7.  International patterns of osteoporosis.

Authors:  B E Nordin
Journal:  Clin Orthop Relat Res       Date:  1966 Mar-Apr       Impact factor: 4.176

8.  Early increase of bone resorption in patients with liver cirrhosis secondary to viral hepatitis.

Authors:  G R Corazza; F Trevisani; M Di Stefano; S De Notariis; G Veneto; L Cecchetti; L Minguzzi; G Gasbarrini; M Bernardi
Journal:  Dig Dis Sci       Date:  2000-07       Impact factor: 3.199

Review 9.  Clinical review 144: Estrogen and the male skeleton.

Authors:  Sundeep Khosla; L Joseph Melton; B Lawrence Riggs
Journal:  J Clin Endocrinol Metab       Date:  2002-04       Impact factor: 5.958

10.  Insulin-like growth factor I: a good indicator of functional hepatocellular capacity in alcoholic liver cirrhosis.

Authors:  A Caufriez; P Reding; D Urbain; J Golstein; G Copinschi
Journal:  J Endocrinol Invest       Date:  1991-04       Impact factor: 4.256

View more
  37 in total

Review 1.  Hepatic osteodystrophy.

Authors:  Angelo Gatta; Alberto Verardo; Marco Di Pascoli; Sandro Giannini; Massimo Bolognesi
Journal:  Clin Cases Miner Bone Metab       Date:  2014-09

2.  Bone Mineral Density, Bone Turnover, and Systemic Inflammation in Non-cirrhotics with Chronic Hepatitis C.

Authors:  Jennifer C Lai; Dolores M Shoback; Jacob Zipperstein; Blanca Lizaola; Samuel Tseng; Norah A Terrault
Journal:  Dig Dis Sci       Date:  2015-01-07       Impact factor: 3.199

3.  Vitamin D status and viral response to therapy in hepatitis C infected children.

Authors:  Azza A Eltayeb; Madleen Adel A Abdou; Amal M Abdel-aal; Mostafa H Othman
Journal:  World J Gastroenterol       Date:  2015-01-28       Impact factor: 5.742

4.  Spectrum of chronic liver disease admitted to a medical college hospital in northern India: is there cause for concern?

Authors:  Ashok Jhajharia; Amit Soni; Rupesh Pokharna; Prachis Ashdhir; Shyam Sunder Sharma; Subhash Nepalia
Journal:  Indian J Gastroenterol       Date:  2014-09

5.  Hepatic osteodystrophy is common in patients with noncholestatic liver disease.

Authors:  N S Choudhary; M Tomar; Y K Chawla; S K Bhadada; N Khandelwal; R K Dhiman; A Duseja; A Bhansali
Journal:  Dig Dis Sci       Date:  2011-05-15       Impact factor: 3.199

6.  Hepatic osteodystrophy: An important matter for consideration in chronic liver disease.

Authors:  Germán López-Larramona; Alfredo J Lucendo; Sonia González-Castillo; José M Tenias
Journal:  World J Hepatol       Date:  2011-12-27

7.  Reduced Serum IGF-1 Associated With Hepatic Osteodystrophy Is a Main Determinant of Low Cortical but Not Trabecular Bone Mass.

Authors:  Zhongbo Liu; Tianzhen Han; Haim Werner; Clifford J Rosen; Mitchell B Schaffler; Shoshana Yakar
Journal:  J Bone Miner Res       Date:  2017-11-06       Impact factor: 6.741

8.  Procollagen type I N-terminal propeptide (PINP) is a marker for fibrogenesis in bile duct ligation-induced fibrosis in rats.

Authors:  Sanne Skovgård Veidal; Efstathios Vassiliadis; Anne-Christine Bay-Jensen; Gervais Tougas; Ben Vainer; Morten Asser Karsdal
Journal:  Fibrogenesis Tissue Repair       Date:  2010-04-01

9.  Study of Hepatic Osteodystrophy in Patients with Chronic Liver Disease.

Authors:  Yogesh Karoli; Ritu Karoli; Jalees Fatima; Mohammad Manhar
Journal:  J Clin Diagn Res       Date:  2016-08-01

10.  Evidence of degraded BMD and geometry at the proximal femora in male patients with alcoholic liver cirrhosis.

Authors:  Dj Culafić; D Djonic; V Culafic-Vojinovic; S Ignjatovic; I Soldatovic; J Vasic; T J Beck; M Djuric
Journal:  Osteoporos Int       Date:  2014-08-30       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.